跳至主要内容
临床试验/EUCTR2017-000042-22-ES
EUCTR2017-000042-22-ES进行中(未招募)1 期

Randomized, pragmátic, open-label clinical trial with blind evaluator, to evaluate the efficacy efficacy of continuing drug treatment in patients with advanced dementia.

GAP MALLORCA0 个研究点开始时间: 2017年3月10日最近更新:

试验速览

阶段
1 期
状态
进行中(未招募)
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • - Patients with severe Alzheimer's disease, with or without a coexisting diagnosis of vascular dementia
  • - Score of =10 on the Standardized Mini-Mental State
  • - Previously treatred with ChI (with or without memantine) for at least 3 months
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) no
  • F.1.2.1 Number of subjects for this age range
  • F.1.3 Elderly (>=65 years) yes
  • F.1.3.1 Number of subjects for this age range 302

排除标准

  • - Patients with another type of advanced dementia.
  • - Life expectancy less than 1 year

研究者

发起方
GAP MALLORCA

相似试验